Core Insights - The brain-computer interface (BCI) sector is experiencing significant advancements, with various developments in policy, clinical applications, and technology integration [1][4][6] Policy Developments - Sichuan province has launched a comprehensive action plan for brain-computer interface and human-computer interaction industries from 2025 to 2030, aiming to develop multiple BCI products and enhance clinical applications [4][5] - National policies are being introduced to support the development of BCI technology, including quality requirements for medical devices using BCI technology and guidelines for pricing new neuro-related medical services [4][5] Market Potential - The global BCI market is projected to reach $3.3 billion by 2027, with a compound annual growth rate (CAGR) of approximately 13.5% since 2019 [2] - In China, the BCI market is expected to grow to 3.2 billion yuan in 2024, with an annual growth rate of 18.8%, and is forecasted to exceed 5.5 billion yuan by 2027 [3] Clinical Applications - BCI technology is being applied in various medical fields, particularly in treating cognitive and motor disorders, with significant clinical trials underway [6][8] - The first clinical ward for BCI technology has been established at Beijing Tiantan Hospital, focusing on research and clinical trials [6] Technological Integration - Synchron has partnered with Apple to integrate its BCI device with Apple products, allowing users to control devices using only their thoughts [7] - Neuralink's BCI device has received "breakthrough medical device" designation from the FDA, targeting patients with severe neurological conditions [7][8] Future Outlook - The BCI industry is expected to continue evolving, with increasing clinical applications and technological advancements, although challenges related to safety, ethics, and privacy remain [8]